Thabet, B., Ahmed, M., Ahmed, M., Mahrous, M. (2023). Outcomes of Endovascular Treatment in Patients with Superficial Femoral Artery In-Stent Restenosis. The Egyptian Journal of Hospital Medicine, 90(2), 2823-2930. doi: 10.21608/ejhm.2023.287336
Bahgat Abdelhamid Thabet; Mahmoud Ismael Ahmed; Mohamed Ibrahim Ahmed; Mark Malak Mahrous. "Outcomes of Endovascular Treatment in Patients with Superficial Femoral Artery In-Stent Restenosis". The Egyptian Journal of Hospital Medicine, 90, 2, 2023, 2823-2930. doi: 10.21608/ejhm.2023.287336
Thabet, B., Ahmed, M., Ahmed, M., Mahrous, M. (2023). 'Outcomes of Endovascular Treatment in Patients with Superficial Femoral Artery In-Stent Restenosis', The Egyptian Journal of Hospital Medicine, 90(2), pp. 2823-2930. doi: 10.21608/ejhm.2023.287336
Thabet, B., Ahmed, M., Ahmed, M., Mahrous, M. Outcomes of Endovascular Treatment in Patients with Superficial Femoral Artery In-Stent Restenosis. The Egyptian Journal of Hospital Medicine, 2023; 90(2): 2823-2930. doi: 10.21608/ejhm.2023.287336
Outcomes of Endovascular Treatment in Patients with Superficial Femoral Artery In-Stent Restenosis
Background: The femoropopliteal artery lesions classed as trans-Atlantic inter-society consensus (TASC) A-C lesions and some TASC D cases should be treated with endovascular therapy, according to current recommendations (Level C, Class I, recommendations based on expert opinion and retrospective studies) Aim: This study aimed to evaluate the effectiveness and safety of endovascular balloon angioplasty in cases of superficial femoral artery stenosis. Patients and Methods: This study was presented to the faculty of medicine's department of vascular surgery at Assiut University Hospital between October 2019 and October 2021. It is a prospective hospital-based study for patients with superficial femoral artery in-stent restenosis. Results: The primary patency rate at 12 months was 82.6%, demonstrating that none of the 23 patients who received effective endovascular therapy experienced any loss of function or passed away during the observation period. Conclusion: Endovascular treatment is a safe and effective way for treating chronic lower limb ischemia caused by SFA-ISR. Both DCB and traditional balloon angioplasty are associated with low post-procedural morbidity and death. It is an excellent surgical replacement with a high rate of technical success. Drug-coated balloon angioplasty is a helpful operation with a significant decrease in recurring stenosis and repeat angioplasty for up to a year because of the anti-proliferative effects of paclitaxel.
View on SCiNiTO
Top